4.7 Review

Chagas Disease An Overview of Clinical and Epidemiological Aspects

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 62, Issue 9, Pages 767-776

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2013.05.046

Keywords

Chagas disease; dilated cardiomyopathy; heart failure

Funding

  1. Merck
  2. Biotronik

Ask authors/readers for more resources

Chagas disease, caused by the parasite Trypanosoma cruzi, is a serious health problem in Latin America and is an emerging disease in non-endemic countries. In recent decades, the epidemiological profile of the disease has changed due to new patterns of immigration and successful control in its transmission, leading to the urbanization and globalization of the disease. Dilated cardiomyopathy is the most important and severe manifestation of human chronic Chagas disease and is characterized by heart failure, ventricular arrhythmias, heart blocks, thromboembolic phenomena, and sudden death. This article will present an overview of the clinical and epidemiological aspects of Chagas disease. It will focus on several clinical aspects of the disease, such as chronic Chagas disease without detectable cardiac pathology, as well as dysautonomia, some specific features, and the principles of treatment of chronic cardiomyopathy. (C) 2013 by the American College of Cardiology Foundation

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available